l
±M·~¤§Âå®v«ü¾É¤U§A°·±d¤~¦³«O»Ù
¾Ú³ø¾É¨Ï¥Î©Ò¿×¤¤ÃÄ¡B°w¨b¡B®ð¥\ªvÀøµ¥´À¥NÀøªk¤§¤H¼Æ¦³³v¦~¼W¥[¤§ÁÍ¶Õ (
¦b¬ü°ê¤§¤j³W¼Ò½Õ¬d³ø§iÅã¥Ü¥Ñ1990¦~¤§34%³v¦~»¼¼W¬°1998¦~¤§42%¡F ¤×¨ä¬OÀù¯g¤ÆÀø¤§¯f±w¡C ºK¿ý¦ÛJournal
of the American Medical Association ,
Nov.11, 1998, Journal of Clinical Oncology, July
2000. )¡F °w¨b¤w©óÁ{§ÉÃÒ¹ê¹ï¤â³N«á¯kµh¤Î¤ÆÀø¤Þ°_¤§¹Ã¦R°Æ§@¥Î¦³¹ê½è¤W¤§§U¯q¡A¤]¬O²Ä¤@Ó°ê»Ú»{¥i¤§ÂåÀø¤è¦¡¡A¤]¬O¶Ç²Î¤¤Â岿Â÷§Î¦Ó¤W¾Ç¶i¤J²{¥N½×ÃÒ¤§¬ì¾Ç»â°ì
( ·íµM¤]»P¤ò¿AªF»P1972¦~¥§§J´Ë³X°Ý¤j³°±È°_¤§¤¤°ê¼ö¦³Ãö¡F¡iµù¸Ñ¡j:
²{¤µ¥¦³q±`·í§@¤@¯ëªvÀø¤§»²§UÀøªk¹ïºô²y¨y¡i¥i¯à¦³®Ä¡j¡F ¹ïÃö¸`ª¢¡B¸gµh¡B°¾ÀYµh¡B¤UIµh¬O¡iªvÀø¦X²z¤§¿ï¾Ü¡j¡F¦ý¹ï¤¤·«á¤§´_°·¡B®ð³Ý¡B±j¤Æ§K¬Ì«h¡i¤£½T©w¡j)¡C ¦Ó¥»¤å«ÂI°Q½×¤§¥]¬A¤¤ÃĤ§°·±d¹«~ÁöµM¦b¤£¦P°ê®a³Q¹ºÂkÃþ¬°¹«~(
food ), ¹«~²K¥[ª«(
food addictive ), Àç¾i¸É¥R«~(
nutritional supplement )©ÎÃĪ«(
drug )¡F¥¦¤£¥u¤¤°êªº¤¤ÃĬy¶Ç¼Æ¤d¦~¡A¦è¤è¤§Ãįó¥ç¦P¼Ë¬y¶Ç¼Æ¦Ê¦~¡F¨Ò¦p©óªk°ê¡N¼w°ê¡N¸q¤j§Q©M·ç¤h¤w±µ¨ü¯óÃĬ°¨Ã¦æÃĪ«¡A¼w°êÁp¨¹EÃĨƩeû·|¤w©ó1998¦~¤½¥¬¯óÃÄÁ{§É«ü¾Éì«h¡A¥¦¤]¬O¼Ú¬ü¤§¼öªù°·±d¹«~¤§«n°Ñ¦Ò¸ê®Æ ( ¨ä¤¤254ºØ¦C¬°³B¤èÃÄ¡A¦Ó126ºØ¦³¦w¥þÅU¼{¦Ó³Q¸T¥Î )¡F^°ê©M²üÄõ¬O¥H¹«~©Î¹«~²K¥[ª«ºÞ²z¡M©ó¬ü°ê²{¤µ¬O¥H¿¯¹¸É¥R«~°·±dº[±Ð¨|ªk(
Dietary Supplement Health and Education Act of 1994 )¥[¥H¬ù§ôºÞ¨î¡A¤¤¯ó
(´Óª«)ÃÄ¥i¨Ì´`2000¦~8¤ëFDA¤½§i¤§¡i´Óª«²£«~»s³y·~¼f¬d·Ç«h¯ó®×Draft
Guidance for Industry- Botanical Drug Product ¡j³W½d¤U¥i¥H«D³B¤èÃÄ(OTC)©Î³B¤è¥Î·sÃÄ(NDA)¨âºØ¤è¦¡®Öã¤W¥«¶ix¬ü°ê¥«³õ¡F ¬G¤¤¦èÂåµ²¦X¬O¥²µM¤§ÁÍ¶Õ ( ¦b¤j³°¾Ú²Îp¦b³£¥«¤§¤¤Âå¶E©Ò´X¥G¤w¥þ±¸¹ºÙ¤¤¦èÂå¾ã¦X¬°¤@¥H²Å¦X®É¥N¤§ÁÍ¶Õ )¡C¤¤ÃĦb¥xÆW¥Ø«e¤w¶}©ñ¡u¤¤Âå°·«O¡v;¡u°·±d¹«~ªk¡v·~¤w©ó1999¦~8
¤ë¥ßªk¹{¥¬¥¿¦¡¹ê¬I¥H¦]À³²{¥N¤H»á¬°¬y¦æ¤§°·±d¹«~¤§»Ý¨D¡A¦Ü¤µ¦@p®Ö¥i17¥ó¡F¨Ì¥\®Ä¤ÀÃþ¤À§O¬°¡i¸zG¹D¥\¯à§ïµ½¡j7¥ó¡B¡i½Õ¸`¦å¯×¡j6¥ó¡B¡i§K¬Ì½Õ¸`¡j2¥ó¡B¡iÅ@¨x¡j1¥ó¡B¡i°©½è«O°·¡j1¥ó¡C©Ò¿×°·±d¹«~¬O«ü¨ä¨ã¦³¯S®íÀç¾i¯À¡A°w¹ï¯S©w¤H¸s¨ã¦³©ú½T«O°·¥\®Ä¤§¦¨¤À¡A¦Ó¨ã¦³¨¬¥H¼W¶i°ê¥Á°·±d©Î´î¤Ö«¤j¯e¯f¦M®`¦]¤l¤§¥\®Ä¡A¦ýµ´¤£¬O¥HªvÀø¯e¯f¬°¥Øªº¤§¯S®íÀç¾i«~¡C
¦³Ãö¤ÑµM¤§´Óª«©Î¨ã¥Íª«¬¡©Ê¤§²£«~¦p¦ó¯Ç¤Jªk³WºÞ²z¡A¥H½T«O¤H̪º°·±d¬O¼öªù¤§¸ÜÃD¡C ®ø¶OªÌ¥i¯à¶R¨ìªº¬OµL®Ä¡N¤£¦w¥þ¡N¼ÐÃѤ£¥¿½T©Î¸Ø¤jªº²£«~¡C©Ò¦³¤§ªk¥O³W©w§¡¦@ÃÑ¡y¦¨¤À³W®æ§t¶qªí¡z¡B¡y¦w¥þµû¦ô³ø§i¡z¡B¡y«O°·¥\®Äµû¦ô³ø§i¤Î¨ä¦¨¤ÀŲ©w³ø§i¤Î¨äÀËÅç¤èªk¡z¡B¡y¨}¦n§@·~³W½d¤§ÃÒ©ú¡z¡B¡y ½Ã¥ÍÀËÅç³W®æ¤Î¨äÀËÅç»P¤@¯ëÀç¾i¦¨¤À¤ÀªR³ø§i¡z¡B¡y¤£¥i¦b¼s§i©Î¥]¸Ë¤Wµù©úÀø®Ä ¡z¡F ¦Ó¥B¥²¶·¦b±M·~ÂåÀø¤Hûªº«ü¥Ü¤U¿ï¾Ü»PªA¥Î¡C ¬G¥Á²³´NÂå®É¤£½×¦p¦ó¥²¶· 1 ). ¦b±M¬ìÂå®v°õ·Ó¤U¤§Âå°|´NÂå¬O³Ì°ò¥»¤§»{ª¾¡A¦]¬°¸zG¬ìÂå®vµLªk¥¿½T¶EÂ_§AªºÃö¸`ª¢¡A ¦]¬°Ãö¸`ª¢¦³¤Q¾lºØ¤£¦P¤§¤ÀÃþ¡A ¤Ï¤§¥ç¦P¡C 2). ¤£¥i¥H¨ì¶È¦³¤@¦ìÂå®v¾n¶E¦Ó©ÛµP«o¬O±Mªv°ü¬ì¡B¤p¨à¬ì¡B°w¨b¬ìݳƤ§¤¤Âå¶E©Ò´NÂå¡A¦]¬°¨S¦³¤@¦ì¤¤Âå®v¬O¤Ñ¤~¡C 3). ¦Û¦æ§ìÃĩάOªA¥Î¿Ë¤Í±ÀÂˤ§ÃĤè¬O§â¦Û¤v·í¥Õ¦Ñ¹«¡A ¥i¯à¾D¨ü¤£¥i¹wª¾¤§«áªG¡C 4).¥h±Ð¾ÇÂå°|´N¶E¬O¸Ñ¨M§A¯fµh³Ì©ú´¼¡Bº¥ý¤§¨M¾Ü¡F ¦]¬°±Ð¾ÇÂå°|´N¬O¦]¬°¥¦ªº±M¬ìÂå®v¦h¦Ó»D¦W¡A¤]¦]¬°¦p¦¹¥Lªº¶EÂ_¸û¨ã¦³¤½«H¤O¡F §Y¨Ï§A±¾¿ù¸¹¤]§O¾á¤ß¡F ¦]¬°Âå®v¦³§iª¾¶EÂ_¤§¸q°È¡A¥L¦³ºÃ°Ý¤]·|«ØÄ³§A¦V¨ä¥L±M¬ìÂå®v´N¶E©Î·|¶E¡C